ConductScience.org, home

Paper545201

Role of cyclopegics in progressive myopia.

Dyer JA. Ophthalmology, 1979. Cited by 41 papers, by iCite.

Cite this record

ConductScience Library. Role of cyclopegics in progressive myopia. Papers, record 545201. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/545201

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Role of cyclopegics in progressive myopia.
PubMed
Journal
Ophthalmology
PubMed
Year
1979
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
41
iCite
Relative citation ratio, by iCite
2.31
iCite
Revised in PubMed
2019-07-26
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Dyer JAJ A

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AtropineMajor topic
MyopiaMajor topic
Adolescent
Child
Eyeglasses
Female
Humans
Male
Mydriatics
Time Factors

Source PubMed

Download CSV of topics

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 41 citations.

PMIDTitleJournalYearIn PapersSource
39027062Impact of atropine use for myopia control on intraocular pressure in children: A comprehensive review including postpupil dilation intraocular pressure changes.Taiwan J Ophthalmol2024https://conductscience.org/library/papers/39027062PubMed
36809645Interventions for myopia control in children: a living systematic review and network meta-analysis.Cochrane Database Syst Rev2023https://conductscience.org/library/papers/36809645PubMed
35918918Myopia, its prevalence, current therapeutic strategy and recent developments: A Review.Indian J Ophthalmol2022https://conductscience.org/library/papers/35918918PubMed
31930781Interventions to slow progression of myopia in children.Cochrane Database Syst Rev2020https://conductscience.org/library/papers/31930781PubMed
29901472A Review of Current Concepts of the Etiology and Treatment of Myopia.Eye Contact Lens2018https://conductscience.org/library/papers/29901472PubMed
28293653Topical Atropine in the Control of Myopia.Med Hypothesis Discov Innov Ophthalmol2016https://conductscience.org/library/papers/28293653PubMed
22161388Interventions to slow progression of myopia in children.Cochrane Database Syst Rev2011https://conductscience.org/library/papers/22161388PubMed
17295137Topical atropine in retarding myopic progression and axial length growth in children with moderate to severe myopia: a pilot study.Jpn J Ophthalmol2007https://conductscience.org/library/papers/17295137PubMed
12386095Myopia: attempts to arrest progression.Br J Ophthalmol2002https://conductscience.org/library/papers/12386095PubMed
8719698Progression of myopia.Trans Am Ophthalmol Soc1995https://conductscience.org/library/papers/8719698PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/545201

GET https://conductscience.org/api/papers/v1/545201/authors